Skip to main content

Apini Therapeutics

Huntingdon, United Kingdom

Apini Therapeutics is a creating novel small chemical two most prevalent types of inflammatory bowel disease.

$2.4M raised
Jun 2025
Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Apini Therapeutics

How much funding has Apini Therapeutics raised?
Apini Therapeutics has raised $2.4M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
Who are Apini Therapeutics's investors?
Apini Therapeutics's investors include Northern Gritstone, Syncona Partners LLP.
Where is Apini Therapeutics headquartered?
Apini Therapeutics is headquartered in Huntingdon, United Kingdom.
What does Apini Therapeutics do?
Apini Therapeutics is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
What stage is Apini Therapeutics at?
Apini Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Apini Therapeutics — Funding & Investors." VCBacked, June 11, 2025, https://www.vcbacked.co/company/apini-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2025). Apini Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/apini-therapeutics
Wikipedia (cite web)
{{cite web |title=Apini Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/apini-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .